Content First Logo

Content First Logo


Research and Information Services

National Venture Capital Association

Patient Capital: How Venture Capital Investment Drives Revolutionary Medical Innovation

Content First was commissioned by the National Venture Capital Association (NVCA) to develop a study on the benefits of venture capital investment in the life sciences, Patient Capital: How Venture Capital Innovation Drives Revolutionary Medical Innovation.  The report was released in June 2007.

Patient Capital Key Findings

  • The nation's most innovative medical breakthroughs have been brought to market by billions of dollars of venture capital investment in life sciences companies
  • Venture backed life sciences companies include Boston Scientific, Amgen, Genentech, Genzyme, and Intuitive Surgical
  • Impact of discoveries by venture capital backed life sciences companies saves millions of lives, improves medical procedures, reduces health care costs, and provides overall economic benefits to the U.S. economy



Client Benefits

This example illustrates how Content First worked with NVCA to make technical economic information accessible to targeted audiences, including:

  • National and State Public Policy Officials
  • The Business Community
  • The Press
  • The Public

Phone: (206) 940-1797
Fax: (202) 318-0875

2004-2008 Content First, LLC

Data    Presentation    Communication